Envestnet Asset Management Inc Crispr Therapeutics Ag Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Envestnet Asset Management Inc holds 54,777 shares of CRSP stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,777

Previous 40,646 34.77%

Holding current value

$2.12 Million

Previous $2.2 Million 17.22%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$44.62 - $62.75 $630,525 - $886,720	14,131 Added 34.77%	54,777 $2.57 Million
Q2 2024 Aug 08, 2024	SELL	$51.17 - $68.18 $34,335 - $45,748	-671 Reduced 1.62%	40,646 $2.2 Million
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $117,093 - $172,001	1,930 Added 4.9%	41,317 $2.82 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $415,821 - $777,162	10,767 Added 37.62%	39,387 $2.47 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $481,451 - $625,813	10,607 Added 58.89%	28,620 $1.3 Million
Q2 2023 Aug 04, 2023	SELL	$43.47 - $67.77 $66,378 - $103,484	-1,527 Reduced 7.81%	18,013 $1.01 Million
Q1 2023 May 11, 2023	SELL	$41.0 - $56.12 $202,745 - $277,513	-4,945 Reduced 20.2%	19,540 $883,000
Q4 2022 Feb 07, 2023	BUY	$39.19 - $65.67 $103,579 - $173,565	2,643 Added 12.1%	24,485 $995,000
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $855 - $1,172	14 Added 0.06%	21,842 $1.43 Million
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $118,406 - $202,220	2,739 Added 14.35%	21,828 $1.33 Million
Q1 2022 May 04, 2022	BUY	$53.19 - $79.24 $141,910 - $211,412	2,668 Added 16.25%	19,089 $1.2 Million
Q4 2021 Feb 04, 2022	BUY	$70.09 - $111.29 $39,670 - $62,990	566 Added 3.57%	16,421 $1.24 Million
Q3 2021 Oct 07, 2021	SELL	$110.2 - $156.64 $632,107 - $898,487	-5,736 Reduced 26.57%	15,855 $1.78 Million
Q2 2021 Aug 04, 2021	BUY	$100.84 - $161.89 $570,351 - $915,649	5,656 Added 35.49%	21,591 $3.5 Million
Q1 2021 May 04, 2021	BUY	$110.72 - $210.04 $714,919 - $1.36 Million	6,457 Added 68.13%	15,935 $1.94 Million
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $434,360 - $944,449	5,452 Added 135.42%	9,478 $1.45 Million
Q3 2020 Oct 09, 2020	BUY	$78.5 - $100.64 $316,041 - $405,176	4,026 New	4,026 $337,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Crispr Therapeutics Ag Transaction History